Blood life
Conditions of acute and chronic anaemia that are the result of either a long-standing medical condition (sickle-cell anaemia) or surgical intervention (chemotherapy) often require the administration of blood transfusions to improve the capacity of the patient's red blood cells to carry oxygen1. Red blood cell (RBC) populations have a short shelf life in storage as a result of biomechanical and biochemical changes that reduce the RBC functionality. This has an impact on the viability and therapeutic benefits of ex vivo RBC transfusions.
Conditions of acute and chronic anaemia that are the result of either a long-standing medical condition (sickle-cell anaemia) or surgical intervention (chemotherapy) often require the administration of blood transfusions to improve the capacity of the patient’s red blood cells to carry oxygen1. Red blood cell (RBC) populations have a short shelf life in storage as a result of biomechanical and biochemical changes that reduce the RBC functionality. This has an impact on the viability and therapeutic benefits of ex vivo RBC transfusions.
A group of investigators in Germany2 has identified a potential solution to this problem, identifying three so-called ‘biomarkers’ that could be used in the development of an assay determining the effect of storage on the functionality of RBC’s. Biomarkers are candidate proteins that can be identified with relative ease and efficiency, have specific physiological functions and specific localisation within a cell. Despite the simple structure and high availability of RBC’s, the high concentration of membrane proteins and intracellular haemoglobin present a complex analytical mixture.
The investigators observed changes in the RBC proteome over a time course of 42 days. 2D DIGE (2-D Fluorescence Difference Gel Electrophoresis) was used to quantitively measure changes in cytosolic proteins over the time course, providing a so-called ‘spot map’, where specific protein spots could be visualised to change over time. Selected protein spots were isolated by trypsin digestion, identified by liquid chromatography– mass spectrometry (LC–MS) and validated by western blotting (the detection of proteins within a gel with a specific antibody). Out of fourteen protein spots identified to be altered post storage, three proteins were selected as potential biomarkers for the monitoring of RBC ageing: transglutaminase 2, ß-actin and copper chaperone for superoxide dismutase.
The discovery of a change in the cytosolic proteome profile and the identification of potential biomarkers is an important step towards improving our understanding of blood storage methods. It may go some way to contributing to the development of specific assays for the measurement and therefore judgement of the therapeutic benefits of blood transfusions to critically ill patients.
1. UK Blood Transfusion & Tissue Transplantation Services: Transfusion Handbook. (www.transfusionguidelines.org.uk)
2. K. Walpurgis et al, Proteomics Journal (2012) DOI: 10.1002/pmic.201200280.
This story originally appeared in The Column. Click here to view that issue.
The Next Frontier for Mass Spectrometry: Maximizing Ion Utilization
January 20th 2025In this podcast, Daniel DeBord, CTO of MOBILion Systems, describes a new high resolution mass spectrometry approach that promises to increase speed and sensitivity in omics applications. MOBILion recently introduced the PAMAF mode of operation, which stands for parallel accumulation with mobility aligned fragmentation. It substantially increases the fraction of ions used for mass spectrometry analysis by replacing the functionality of the quadrupole with high resolution ion mobility. Listen to learn more about this exciting new development.
Liquid Chromatography to Analyze Vitamin D Proteins in Psoriasis Patients
January 21st 2025Can a protein involved in delivering Vitamin D to target tissues have an altered serum profile in psoriasis patients with cardiovascular disease? Researchers used liquid chromatography (LC) to help find out.
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
A Guide To Finding the Ideal Syringe and Needle
January 20th 2025Hamilton has produced a series of reference guides to assist science professionals in finding the best-suited products and configurations for their applications. The Syringe and Needle Reference Guide provides detailed information on Hamilton Company’s full portfolio of syringes and needles. Everything from cleaning and preventative maintenance to individual part numbers are available for review. It also includes selection charts to help you choose between syringe terminations like cemented needles and luer tips.
